Skip to main content

Want a detailed portfolio tracker?

CollPlant Biotechnologies Ltd New (CLGN) P/E (2018 - 2026)

CollPlant Biotechnologies Ltd New (CLGN) P/E from Jan 30, 2018 to Jul 20, 2026. The TTM CollPlant Biotechnologies Ltd New (CLGN) P/E is -0.31. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of CollPlant Biotechnologies Ltd New (CLGN)

YearP/EChange
2026-0.31-79.20%
2025-1.50-39.61%
2024-2.48-76.06%
2023-10.37+85.12%
2022-5.60-97.84%
2021-259.43+1920.12%
2020-12.84+277.97%
2019-3.40+48.81%
2018-2.28N/A

Comparison CollPlant Biotechnologies Ltd New (CLGN) P/E with competitors

CollPlant Biotechnologies Ltd New (CLGN) P/E is -0.31.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.55%
NBYStablecoin Development Corp0.00-101.38%
ENLVEnlivex Ltd0.07-123.99%
FGENFibroGen Inc0.24-176.98%
CHRSCoherus Biosciences Inc0.85-372.12%
FBIOFortress Biotech Inc0.95-404.35%
ORMPOramed Pharmaceuticals Inc1.50-582.02%
AGENAgenus Inc3.01-1065.17%
INVAInnoviva Inc3.15-1111.48%
VXRTVaxart Inc3.55-1238.39%
CRMDCorMedix Inc3.63-1263.62%
CVACCureVac N.V.4.45-1525.71%
GLPGGalapagos NV4.86-1658.22%
SRPTSarepta Therapeutics Inc4.88-1665.66%
ABEOAbeona Therapeutics Inc5.39-1827.75%
ABUSArbutus Biopharma Corp5.60-1894.49%
ZVRAZevra Therapeutics Inc5.89-1988.01%
SPROSpero Therapeutics Inc6.23-2097.43%
CGENCompugen Ltd6.31-2124.85%
RIGLRigel Pharmaceuticals6.87-2303.84%
SLXNSilexion Therapeutics Corp7.30-2439.82%
OMEROmeros Corporation9.26-3069.24%
AUPHAurinia Pharmaceuticals Inc9.58-3173.86%
PLXProtalix BioTherapeutics Inc10.89-3592.70%
ACADAcadia Pharmaceuticals Inc11.73-3861.30%
TBPHTheravance Biopharma Inc12.26-4032.42%
ADMAAdma Biologics Inc12.42-4082.46%
HRMYHarmony Biosciences Holdings Inc13.82-4532.09%
SABSSAB Biotherapeutics Inc14.14-4633.43%
NAGENiagen Bioscience Inc14.82-4852.12%
INCYIncyte Corp15.82-5174.24%
REGNRegeneron Pharmaceuticals Inc15.86-5185.18%
PBYIPuma Biotechnology Inc17.32-5653.09%
CPRXCatalyst Pharmaceuticals Inc17.44-5692.73%
EXELExelixis Inc17.54-5724.38%
TGTXTG Therapeutics Inc18.97-6182.36%
MDXGMimedx Group Inc20.55-6691.13%
XOMAXOMA Royalty Corp22.87-7436.03%
ARGXArgen X SE24.30-7892.50%
CTMXCytomX Therapeutics Inc24.82-8060.26%
XOMAOXOMA Royalty Corp25.34-8228.22%
HALOHalozyme Therapeutics Inc25.62-8317.66%
XOMAPXOMA Royalty Corp25.67-8332.54%
VRTXVertex Pharmaceuticals Inc27.99-9078.06%
RPRXRoyalty Pharma plc - Class A28.69-9300.25%
SLNOSoleno Therapeutics Inc29.02-9405.37%
ASNDAscendis Pharma A/S30.09-9748.60%
LGNDLigand Pharmaceuticals Inc - Class B37.91-12258.58%
APLSApellis Pharmaceuticals Inc39.02-12614.31%
BMRNBiomarin Pharmaceutical Inc42.21-13637.56%
KRYSKrystal Biotech Inc45.34-14641.89%
ONCBeiGene Ltd69.54-22402.00%
PHARPharming Group N.V.75.03-24161.12%
TECHBio-Techne Corp101.96-32798.62%
VCELVericel Corp109.92-35352.38%
ALNYAlnylam Pharmaceuticals Inc117.96-37932.06%
GMABGenmab140.29-45092.03%
TLXTelix Pharmaceuticals Ltd162.15-52103.31%
CORTCorcept Therapeutics Inc212.86-68364.58%